# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-059027
Filing Date
2021-04-30
Accepted
2021-04-30 16:14:04
Documents
4

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tm212548d3_defa14a.htm | DEFA14A | 23644
2 | GRAPHIC | tm212548d3_defa14aimg001.jpg | GRAPHIC | 175451
3 | GRAPHIC | tm212548d3_defa14aimg002.jpg | GRAPHIC | 296014
4 | GRAPHIC | tm212548d3_defa14aimg003.jpg | GRAPHIC | 189345
| Complete submission text file | 0001104659-21-059027.txt |  | 919093

Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37977 | Film No.: 21878160
SIC: 2834 Pharmaceutical Preparations